MediTrans

A clinical and regulatory communication partner
supporting CRO and pharma global development and approval.

What we do

With medical writing at the center, we own clinical and regulatory document authoring, review, and consistency.
Where needed, we connect multilingual document support, audit/inspection communication, and Latin America CRO execution in one workflow.

Vision

To become the trusted partner that reduces document, regulatory,
and on-site communication risk across global clinical development and approval.

Mission

Keep CRO and pharma development and approval communication accurate and consistent
through medical writing and clinical/regulatory documentation.

How we work

Clinical & regulatory depth

We build documents with life-science specialists who understand clinical and regulatory context.

Document & terminology consistency

Project terminology and style standards keep messaging aligned across submission documents.

Delivery ownership

We hold schedule and quality commitments, and raise issues early.

Practical expansion

We grow digital touchpoints and Latin America CRO execution alongside core services.

CEO Message

The pace and quality of clinical development are decided in the documents

In global clinical development and regulatory approval, document readiness and communication consistency are among the most frequent sources of delay. MediTrans has built its practice around medical writing, taking ownership of clinical and regulatory document authoring, review, and terminological alignment.

Supported by a life-science expert network and a quality management system, we provide practical delivery that reflects each project’s regulatory requirements, timelines, and stakeholder structure. Where needed, we extend support to audit and inspection communication and to our Latin America CRO affiliate—so documentation and field execution remain connected.

MediTrans will continue to serve as a clinical and regulatory communication partner that protects development timelines, reduces regulatory risk, and strengthens the quality of global submissions.

Chief Executive Officer

Giai Kwon

Organization

Business Operations

HR, administration, finance

Sales & Marketing

Sales, marketing, client success

Clinical & Regulatory Delivery

Medical writing, clinical/regulatory documentation, expert network

MediTrans Clinical S.A.S.

Colombia affiliate · Latin America Clinical CRO

Explore Latin America CRO

History

2026

Strengthened core services and global & digital expansion

Reinforced medical writing and clinical/regulatory documentation, with stronger DM/STAT collaboration.
Launched Doctor's Note as a digital expansion app on Android and iOS.
Established Latin America CRO capability through affiliate MediTrans Clinical S.A.S. in Colombia.

2025

Expansion of clinical execution and regulatory communication

Launched audit/inspection communication support for pharma and biotech sites.
Expanded multilingual document support for global submissions and IR materials, and began validating digital touchpoints for individual users.

2024

International certification and medical writing scale-up

Official launch of medical writing services for clinical documentation.
Obtained ISO 9001:2015 quality management certification.
Expanded the global professional network, including ATA membership.

2023

Expanded global submission and commercial document support

Expanded regulatory and commercial document communication support for companies entering overseas markets.
Strengthened client competitiveness with multilingual web and IR document readiness.

2022

Brand identity refresh

Changed the company name from “Kbon Solutions” to “MediTrans” to clarify our positioning
as a clinical and regulatory communication specialist for pharma and biotech.

2021

Completion of global expert network

Built a network of over 200 licensed medical and life‑science professionals.
Secured coverage across Asia, Europe, and the Americas.

2020

Company founded & services launched

Founded as Kbon Solutions and launched clinical/regulatory communication services for pharma and biotech.
Entered the market by supporting urgent vaccine-related documentation and communication needs during the COVID‑19 pandemic.

Certifications

2024-

ISO 9001:2015 Quality Management System

International Organization for Standardization (ISO)

2025

ATA member (American Translators Association)

Global professional network

2026

Women-Owned Enterprise Certification

Ministry of SMEs and Startups (MSS)